Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke

Summary

The purpose of this single-center, randomized, double-blind, controlled trial is to clarify the clinical efficacy and safety of Getong Tongluo Capsule in patients with ischemic stroke. Combined with gut microbiome and metabolomics techniques, investigators will explore whether this medicine exerts neuroprotective effects via the gut-brain axis. Investigators will further verify its pharmacological mechanism through animal experiments to provide evidence for its clinical application.

Timeline

Start

2026-08-01

Primary completion

2029-07-31

Completion

2030-01-31

Drugs

Indications